Literature DB >> 1981539

Metabolism and covalent binding of [14C]toluene by human and rat liver microsomal fractions and liver slices.

D E Chapman1, T J Moore, S R Michener, G Powis.   

Abstract

The in vitro metabolism of [14C]toluene by liver microsomes and liver slices from male Fischer F344 rats and human subjects has been compared. Rat liver microsomes produced only benzyl alcohol from toluene. Liver microsomes from human subjects metabolized toluene to benzyl alcohol, benzaldehyde, and benzoic acid. Liver microsomes from one human donor also produced p-cresol and o-cresol. The overall rate of toluene metabolism by human liver microsomes was 9-fold greater than by rat liver microsomes. Human liver microsomal metabolism of benzyl alcohol to benzaldehyde required NADPH and was inhibited by carbon monoxide and high pH (pH 10). but was not inhibited by ADP-ribose or sodium azide. These results suggest that cytochrome P-450, rather than alcohol dehydrogenase, was responsible for the metabolism of benzyl alcohol to benzaldehyde. Human and rat liver slices metabolized toluene to hippuric acid and benzoic acid. The overall rate of toluene metabolism by human liver slices was 1.3-fold greater than by rat liver slices. Cresols and cresol conjugates were not detected in human or rat liver slice incubations. Covalent binding of [14C]toluene to human liver microsomes and slices was 21-fold and 4-fold greater than to the comparable rat liver preparations. Covalent binding did not occur in the absence of NADPH, was significantly decreased by coincubation with cysteine, glutathione, or superoxide dismutase, and was unaffected by coincubation with lysine. Protease and ribonuclease digestion decreased the amount of toluene covalently bound to human liver microsomes by 78% and 27% respectively. Acid washing of human liver microsomes had no effect on covalent binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981539

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I.

Authors:  H Umesha Shetty; Sami S Zoghbi; Jeih-San Liow; Masanori Ichise; Jinsoo Hong; John L Musachio; Christer Halldin; Jurgen Seidel; Robert B Innis; Victor W Pike
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

2.  Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.

Authors:  G Powis; M J Seewald; D Melder; M Hoke; C Gratas; T A Christensen; D E Chapman
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

Authors:  Andrew Campbell
Journal:  Regul Toxicol Pharmacol       Date:  2009-01-23       Impact factor: 3.271

4.  Disposition and metabolism in mice of the potential antitumor and anti-human immunodeficiency virus-1 agent, 2-chloro-2',3'-dideoxyadenosine.

Authors:  D E Chapman; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Uncoventional views on certain aspects of toxin-induced metabolic acidosis.

Authors:  Man S Oh
Journal:  Electrolyte Blood Press       Date:  2010-06-30

Review 6.  Laboratory approach for diagnosis of toluene-based inhalant abuse in a clinical setting.

Authors:  Raka Jain; Arpita Verma
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar

7.  The protective effect of Buffalo's milk against toluene induced-nephrotoxicity in rats.

Authors:  Maryam Afravy; Kambiz Angali; Ali Khodadadi; Massumeh Ahmadizadeh
Journal:  J Nephropathol       Date:  2016-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.